These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31290667)

  • 1. Predicting the Affinity of Peptides to Major Histocompatibility Complex Class II by Scoring Molecular Dynamics Simulations.
    Ochoa R; Laio A; Cossio P
    J Chem Inf Model; 2019 Aug; 59(8):3464-3473. PubMed ID: 31290667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
    Appella E; Padlan EA; Hunt DF
    EXS; 1995; 73():105-19. PubMed ID: 7579970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
    Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
    Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
    Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
    Front Immunol; 2018; 9():1795. PubMed ID: 30127785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of Ab initio predictions of peptide binding to MHC class II molecules.
    Zhang H; Wang P; Papangelopoulos N; Xu Y; Sette A; Bourne PE; Lund O; Ponomarenko J; Nielsen M; Peters B
    PLoS One; 2010 Feb; 5(2):e9272. PubMed ID: 20174654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the binding affinity of MHC class II peptides.
    Altiparmak F; Akalin A; Ferhatosmanoglu H
    Comput Syst Bioinformatics Conf; 2006; ():331-4. PubMed ID: 17369651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift-invariant adaptive double threading: learning MHC II-peptide binding.
    Zaitlen N; Reyes-Gomez M; Heckerman D; Jojic N
    J Comput Biol; 2008 Sep; 15(7):927-42. PubMed ID: 18771399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.
    Yaneva R; Springer S; Zacharias M
    Biopolymers; 2009 Jan; 91(1):14-27. PubMed ID: 18767126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study.
    Zacharias M; Springer S
    Biophys J; 2004 Oct; 87(4):2203-14. PubMed ID: 15454423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-molecule motions of MHC class II rely on bound peptides.
    Kozono H; Matsushita Y; Ogawa N; Kozono Y; Miyabe T; Sekiguchi H; Ichiyanagi K; Okimoto N; Taiji M; Kanagawa O; Sasaki YC
    Biophys J; 2015 Jan; 108(2):350-9. PubMed ID: 25606683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative prediction of MHC-II binding affinity using particle swarm optimization.
    Zhang W; Liu J; Niu Y
    Artif Intell Med; 2010 Oct; 50(2):127-32. PubMed ID: 20541921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian regression approach to the prediction of MHC-II binding affinity.
    Zhang W; Liu J; Niu YQ; Wang L; Hu X
    Comput Methods Programs Biomed; 2008 Oct; 92(1):1-7. PubMed ID: 18562039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Static energy analysis of MHC class I and class II peptide-binding affinity.
    Davies MN; Flower DR
    Methods Mol Biol; 2007; 409():309-20. PubMed ID: 18450011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
    Kashyap M; Jaiswal V; Farooq U
    Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of peptide-MHC binding affinity using SVRMHC.
    Liu W; Wan J; Meng X; Flower DR; Li T
    Methods Mol Biol; 2007; 409():283-91. PubMed ID: 18450008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motifs and supermotifs for MHC class II binding peptides.
    Sinigaglia F; Hammer J
    J Exp Med; 1995 Feb; 181(2):449-51. PubMed ID: 7836904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.